BioSpace News Archive

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that members of its management team will be participating in the Virtual 11th Annual SVB Leerink Global Healthcare Conference.

Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH, a German manufacturer of innovative and high-quality raw materials in molecular diagnostics.

According to Emergen Research, the global big data in healthcare market size was USD 23.83 billion in 2020 and is expected to reach USD 93.32 billion in 2028 and register a revenue CAGR of 19.6% during the forecast period, 2021-2028.

Growing geriatric population, rising awareness of health & wellness among people, increasing demand for generic drugs, and rapid adoption of new and more innovative techniques for drug discovery are other important factors expected to boost market revenue growth over the forecast period.

Unicycive Therapeutics, Inc. today announced the acceptance of two abstracts supporting the potential efficacy and safety of Renazorb (lanthanum dioxycarbonate) to be presented as posters at the National Kidney Foundation (NKF) Spring Clinical Meeting taking place April 6-10, 2022 in Boston.

Castle Biosciences, Inc. today announced that it has received a 2022 Top Workplaces USA award from Energage.

KalVista Pharmaceuticals, Inc., announced that the compensation committee of KalVista’s board of directors granted four newly-hired employees inducement options to purchase an aggregate of 19,000 shares of KalVista common stock on February 1, 2022 as inducements material to each employee entering into employment with KalVista.

ADC Therapeutics SA announced that Chris Martin, PhD, Chief Executive Officer, will participate in a fireside chat at the virtual Guggenheim Oncology Conference on Wednesday, February 9th at 9:30 a.m. EST.

Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.

Medicenna Therapeutics Corp. today announced that it will host a conference call and live webcast on February 9, 2022 at 8:30 AM ET to report its third quarter fiscal 2022 financial results and operational highlights.